Last10K.com

Array Biopharma Inc (ARRY) SEC Filing 8-K Material Event for the period ending Friday, October 26, 2018

Array Biopharma Inc

CIK: 1100412

View differences made from one to another to evaluate Array Biopharma Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Array Biopharma Inc.

Continue

Assess how Array Biopharma Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Array Biopharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Array Biopharma Inc provided additional information to their SEC Filing as exhibits

CIK: 1100412
Form Type: 8-K Corporate News
Accession Number: 0001100412-18-000032
Submitted to the SEC: Fri Oct 26 2018 4:44:11 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Bylaw Change
  2. Financial Exhibit
  3. Vote of Security Holders

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1100412/0001100412-18-000032.htm